MiNK Therapeutics (6Q40.F) Q4 2024 Earnings

Nov 14Confirmed
Q4 2024
-0.76
-0.67
-0.57
-0.47

Details

Expected EPS
-0.76036142322
Actual EPS
-0.47483
Surprise EPS
0.29
Surprise Percent
+37.55%

Description

⁨MiNK Therapeutics⁩ (⁦6Q40.F⁩) has reported earnings of ⁦-0.47483⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts